Published in

American Association for the Advancement of Science, Science Advances, 2(7), 2021

DOI: 10.1126/sciadv.abb1703

Links

Tools

Export citation

Search in Google Scholar

Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Gene therapy for tuberous sclerosis type 2 proved beneficial in a mouse model of the disease, extending life span.